Skip to main content

Created with Sketch.

NewSTEPs
  • Log in
  • Sign up

Main Menu

  • About NewSTEPs
    • Screening Successes
    • Continuous Quality Improvement
    • Request Site Review
    • FAQs
  • Newborn Screening Disorders
  • Resource Library
    • Toolkits
    • Webinars & Events
  • Data Center
    • NBS Cases
    • Quality Indicators
    • State Profiles
    • Dashboards and Reports
    • Request Data
  • Manage Data
    • User Management
    • Submit Confirmed Case Data
    • Submit Quality Indicator Data
    • Submit State Profile Data
    • Data Dictionary
  • Log in
  • Sign up
  • NewSTEPs
  • Resource Library
  • Evidence for an Association between Infant Mortality and Homozygosity for the Arctic Variant of Carnitine Palmitoyltransferase 1A

Evidence for an Association between Infant Mortality and Homozygosity for the Arctic Variant of Carnitine Palmitoyltransferase 1A

Date: January 2016

This open-access article successes the association between the high prevalence of CPT 1A in the Alaska Native population and the increased risk of infant mortality.

Evidence for an association between infant mortality and homozygosity for the arctic variant of carnitine palmitoyltransferase

Tags

  • Publications

Share

Outdated Browser

This website is not compliant with Internet Explorer. Please continue your experiense using Microsoft Edge, or another up-to-date browser.

This resource, a program of APHL, was developed by funding from the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under grant number U22MC24078 for $2,300,000.

Follow

newsteps@aphl.org
© Copyright 2025 Association of Public Health Laboratories